ArticleHaematologica2021

Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis.

Zuzana Chyra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.